Literature DB >> 15877986

Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms.

Rohit Bhatheja1, Gary S Francis, Claire E Pothier, Michael S Lauer.   

Abstract

Although it is well established that a blunted chronotropic response to exercise is associated with a higher risk of death, recent data suggest a similar association between mortality risk and blunted heart rate response to vasodilatory stress. We investigated the heart rate response to dipyridamole-induced stress as a predictor of death in the setting of normal myocardial perfusion and a normal electrocardiogram. We followed 1,087 patients for 8 years (range 5.7 to 11.8) who underwent dipyridamole vasodilator stress and had normal perfusion scans and electrocardiograms. None had heart failure, known left ventricular systolic dysfunction, pacemaker implantation, or valve disease. Heart rate response was assessed as the ratio of heart rate at peak stress to heart rate at rest. The primary end point was all-cause mortality. Quartile values for the peak-to-rest heart rate ratio were <1.19, 1.19 to 1.30, 1.31 to 1.44, and >1.44. There were 246 deaths. Death rates according to quartiles of heart rate ratio were 103 of 271 (38%), 64 of 272 (24%), 52 of 272 (19%), and 27 of 272 (10%). After adjusting for age, gender, heart rate at rest, blood pressure response, standard cardiovascular risk factors, and other confounders, a blunted heart rate response remained predictive of death (adjusted hazard ratio for lowest vs highest quartile 3.3, 95% confidence interval 2.1 to 5.1, p <0.0001). When considered as a continuous variable, the logarithm of the heart rate ratio was the strongest predictor of death, aside from age. Thus, among patients who have normal myocardial perfusion and normal electrocardiograms, a blunted heart rate response to vasodilator stress is predictive of a marked increase in risk of death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15877986     DOI: 10.1016/j.amjcard.2005.01.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

1.  Heart rate response during vasodilator stress myocardial perfusion imaging: Mechanisms and implications.

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

2.  Heart rate response to regadenoson: Making the case for its value in clinical practice.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-08-27       Impact factor: 5.952

3.  Symptom-limited exercise during vasodilator stress: best of both worlds?

Authors:  Kevin A Bybee; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

4.  Relationship between gated myocardial perfusion SPECT findings and hemodynamic, electrocardiographic, and heart rate changes after Dipyridamole infusion.

Authors:  Arash Gholoobi; Narjess Ayati; Alireza Baghyari; Mohsen Mouhebati; Baharak Atar; Vahid Reza Dabbagh Kakhki
Journal:  Int J Cardiovasc Imaging       Date:  2017-02-01       Impact factor: 2.357

Review 5.  Review of cardiovascular imaging in the journal of nuclear cardiology in 2016: Part 2 of 2-myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2017-04-06       Impact factor: 5.952

6.  Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease.

Authors:  Punitha Arasaratnam; Masoud Sadreddini; Yeung Yam; Vinay Kansal; Sharmila Dorbala; Marcelo F Di Carli; Rob S Beanlands; Michael E Merhige; Brent A Williams; Emir Veledar; James K Min; Li Chen; Terrence D Ruddy; Guido Germano; Daniel S Berman; Leslee J Shaw; Benjamin J W Chow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-27       Impact factor: 9.236

7.  Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.

Authors:  Wael AlJaroudi; Tania Campagnoli; Ibtihaj Fughhi; Marwan Wassouf; Amjad Ali; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2015-08-22       Impact factor: 5.952

Review 8.  Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review.

Authors:  Aviral Vij; Yasmeen Golzar; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2017-06-26       Impact factor: 5.952

9.  Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging.

Authors:  Shishir Mathur; Anuj R Shah; Alan W Ahlberg; Deborah M Katten; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2010-05-19       Impact factor: 5.952

Review 10.  The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging.

Authors:  Navkaranbir S Bajaj; Siddharth Singh; Ayman Farag; Stephanie El-Hajj; Jack Heo; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-03-03       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.